Merck & Co Inc (NYSE:MRK)
| 106.96 Delayed Data As of 4:00pm ET |  +2.16 / +2.06%Today’s Change | 80.73 Today|||52-Week Range 115.49 | -3.60% Year-to-Date |
Latest MRK News | Press Releases
Today’s Trading
| Previous close | 104.80 |
| Today’s open | 105.90 |
| Day’s range | 105.72 - 107.61 |
| Volume | 7,563,141 |
| Average volume (3 months) | 9,038,994 |
| Market cap | $266.0B |
Data as of 4:00pm ET, 03/27/2023
Growth & Valuation
| Earnings growth (last year) | +11.18% |
| Earnings growth (this year) | -7.63% |
| Earnings growth (next 5 years) | +14.00% |
| Revenue growth (last year) | +19.56% |
| P/E ratio | 18.7 |
| Price/Sales | 4.82 |
| Price/Book | 5.78 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVONovo Nordisk | +1.95 | +1.28% |
| ABBVAbbVie | -0.52 | -0.33% |
| PFEPfizer | -0.15 | -0.37% |
| LLYEli Lilly and Co | -1.37 | -0.41% |
Data as of 4:00pm ET, 03/27/2023
Financials
| Next reporting date | April 27, 2023 |
| EPS forecast (this quarter) | $1.37 |
| Annual revenue (last year) | $58.5B |
| Annual profit (last year) | $14.5B |
| Net profit margin | 24.83% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Kenilworth, New Jersey |
Forecasts
